Results

Reset All Filters

Manufacturer:Adooq remove filter

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

Click on the organs and learn more about cancer types

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

Name	Type	Specific against	Item no.	Amount	Price
p32 Inhibitor M36 25mg	Inhibitors	Other	A18846-25 Adooq	25 mg	Login Compare	p32 Inhibitor M36 25mg
p32 Inhibitor M36 100mg	Inhibitors	Other	A18846-100 Adooq	100 mg	Login Compare	p32 Inhibitor M36 100mg
4-epi-Chlortetracycline Hydrochloride 500??g	Inhibitors	Other	A12848-0.5 Adooq	0,5 mg	Login Compare	4-epi-Chlortetracycline Hydrochloride 500??g
4-epi-Chlortetracycline Hydrochloride 1mg	Inhibitors	Other	A12848-1 Adooq	1 mg	Login Compare	4-epi-Chlortetracycline Hydrochloride 1mg
Birinapant (TL32711) 2mg	Inhibitors	Other	A12738-2 Adooq	2 mg	Login Compare	Birinapant (TL32711) 2mg
Birinapant (TL32711) 100mg	Inhibitors	Other	A12738-100 Adooq	100 mg	Login Compare	Birinapant (TL32711) 100mg
LSD1-C76 2mg	Inhibitors	Other	A12927-2 Adooq	2 mg	Login Compare	LSD1-C76 2mg
LSD1-C76 5mg	Inhibitors	Other	A12927-5 Adooq	5 mg	Login Compare	LSD1-C76 5mg
LSD1-C76 10mg	Inhibitors	Other	A12927-10 Adooq	10 mg	Login Compare	LSD1-C76 10mg
Combretastatin A4 5mg	Inhibitors	Other	A12601-5 Adooq	5 mg	Login Compare	Combretastatin A4 5mg
Combretastatin A4 10mM * 1mL in DMSO	Inhibitors	Other	A12601-10mM-D Adooq	10mM x 1mL in DMSO	Login Compare	Combretastatin A4 10mM * 1mL in DMSO
CYP17-IN-1 2mg	Inhibitors	Other	A12622-2 Adooq	2 mg	Login Compare	CYP17-IN-1 2mg
CYP17-IN-1 25mg	Inhibitors	Other	A12622-25 Adooq	25 mg	Login Compare	CYP17-IN-1 25mg
CYP17-IN-1 50mg	Inhibitors	Other	A12622-50 Adooq	50 mg	Login Compare	CYP17-IN-1 50mg
Cucurbitacin I 10mg	Inhibitors	Other	A15363-10 Adooq	10 mg	Login Compare	Cucurbitacin I 10mg
Cucurbitacin IIb 10mg	Inhibitors	Other	A15405-10 Adooq	10 mg	Login Compare	Cucurbitacin IIb 10mg
Cucurbitacin IIb 25mg	Inhibitors	Other	A15405-25 Adooq	25 mg	Login Compare	Cucurbitacin IIb 25mg
mTOR inhibitor (mTOR-IN-1) 1mg	Inhibitors	Other	A15175-1 Adooq	1 mg	Login Compare	mTOR inhibitor (mTOR-IN-1) 1mg
mTOR inhibitor (mTOR-IN-1) 25mg	Inhibitors	Other	A15175-25 Adooq	25 mg	Login Compare	mTOR inhibitor (mTOR-IN-1) 25mg
mTOR inhibitor (mTOR-IN-1) 100mg	Inhibitors	Other	A15175-100 Adooq	100 mg	Login Compare	mTOR inhibitor (mTOR-IN-1) 100mg
mTOR inhibitor (mTOR-IN-1) 500mg	Inhibitors	Other	A15175-500 Adooq	500 mg	Login Compare	mTOR inhibitor (mTOR-IN-1) 500mg
mTOR inhibitor (mTOR-IN-1) 10mM * 1mL in DMSO	Inhibitors	Other	A15175-10mM-D Adooq	10mM x 1mL in DMSO	Login Compare	mTOR inhibitor (mTOR-IN-1) 10mM * 1mL in DMSO
Retaspimycin 25mg	Inhibitors	Other	A15221-25 Adooq	25 mg	Login Compare	Retaspimycin 25mg
Retaspimycin 50mg	Inhibitors	Other	A15221-50 Adooq	50 mg	Login Compare	Retaspimycin 50mg
Retaspimycin 100mg	Inhibitors	Other	A15221-100 Adooq	100 mg	Login Compare	Retaspimycin 100mg

Name Price

p32 Inhibitor M36 25mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18846-25
Amount	25 mg
Available

p32 Inhibitor M36 100mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A18846-100
Amount	100 mg
Available

4-epi-Chlortetracycline Hydrochloride 500??g

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A12848-0.5
Amount	0,5 mg
Available

4-epi-Chlortetracycline Hydrochloride 1mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A12848-1
Amount	1 mg
Available

Birinapant (TL32711) 2mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A12738-2
Amount	2 mg
Available

Birinapant (TL32711) 100mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A12738-100
Amount	100 mg
Available

LSD1-C76 2mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A12927-2
Amount	2 mg
Available

LSD1-C76 5mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A12927-5
Amount	5 mg
Available

LSD1-C76 10mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A12927-10
Amount	10 mg
Available

Combretastatin A4 5mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A12601-5
Amount	5 mg
Available

Combretastatin A4 10mM * 1mL in DMSO

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A12601-10mM-D
Amount	10mM x 1mL in DMSO
Available

CYP17-IN-1 2mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A12622-2
Amount	2 mg
Available

CYP17-IN-1 25mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A12622-25
Amount	25 mg
Available

CYP17-IN-1 50mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A12622-50
Amount	50 mg
Available

Cucurbitacin I 10mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A15363-10
Amount	10 mg
Available

Cucurbitacin IIb 10mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A15405-10
Amount	10 mg
Available

Cucurbitacin IIb 25mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A15405-25
Amount	25 mg
Available

mTOR inhibitor (mTOR-IN-1) 1mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A15175-1
Amount	1 mg
Available

mTOR inhibitor (mTOR-IN-1) 25mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A15175-25
Amount	25 mg
Available

mTOR inhibitor (mTOR-IN-1) 100mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A15175-100
Amount	100 mg
Available

mTOR inhibitor (mTOR-IN-1) 500mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A15175-500
Amount	500 mg
Available

mTOR inhibitor (mTOR-IN-1) 10mM * 1mL in DMSO

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A15175-10mM-D
Amount	10mM x 1mL in DMSO
Available

Retaspimycin 25mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A15221-25
Amount	25 mg
Available

Retaspimycin 50mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A15221-50
Amount	50 mg
Available

Retaspimycin 100mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A15221-100
Amount	100 mg
Available

Oncology

Click on the organs and learn more about cancer types

General information

Relevant products for oncology research

Contact

About Hölzel

Service

Infodesk

REGISTER & SECURE BENEFITS

Filter Results

Oncology

Click on the organs and learn more about cancer types

General information

Relevant products for oncology research

Contact

About Hölzel

Service

Infodesk